Forte Biosciences (FBRX) Shares Outstanding (Weighted Average) (2016 - 2020)
Historic Shares Outstanding (Weighted Average) for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to $11.2 million.
- Forte Biosciences' Shares Outstanding (Weighted Average) fell 9946.83% to $11.2 million in Q3 2020 from the same period last year, while for Sep 2020 it was $11.2 million, marking a year-over-year decrease of 9946.83%. This contributed to the annual value of $2.1 million for FY2019, which is 8949.0% down from last year.
- According to the latest figures from Q3 2020, Forte Biosciences' Shares Outstanding (Weighted Average) is $11.2 million, which was down 9946.83% from $3.7 million recorded in Q2 2020.
- In the past 5 years, Forte Biosciences' Shares Outstanding (Weighted Average) ranged from a high of $2.1 billion in Q1 2020 and a low of $2.1 million during Q4 2019
- Its 5-year average for Shares Outstanding (Weighted Average) is $342.8 million, with a median of $16.3 million in 2017.
- Per our database at Business Quant, Forte Biosciences' Shares Outstanding (Weighted Average) soared by 1048241.36% in 2019 and then crashed by 9982.69% in 2020.
- Quarter analysis of 5 years shows Forte Biosciences' Shares Outstanding (Weighted Average) stood at $2.2 million in 2016, then soared by 563.99% to $14.6 million in 2017, then skyrocketed by 37.32% to $20.1 million in 2018, then crashed by 89.49% to $2.1 million in 2019, then skyrocketed by 431.67% to $11.2 million in 2020.
- Its Shares Outstanding (Weighted Average) stands at $11.2 million for Q3 2020, versus $3.7 million for Q2 2020 and $2.1 billion for Q1 2020.